Saturday 17 October 2026
Export NEPTF’s income statement to Excel — free account
Neptune Wellness Solutions Inc.
NEPTF Healthcare Drug Manufacturers Specialty & Generic
Revenue growth for five consecutive years, operating cash flow growth for five.
0.00
0.00
NaN
Follow NEPTF
| Feb '16 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 5 | 3 | 2 | 2 | 4 | 3 |
P/E ratio |
0.00 | 0.00 | 25.26 | 70.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
6.48 | 4.14 | 2.26 | 6.27 | 13.73 | 4.74 | 4.49 | 0.77 | 0.12 |
Altman Z-Score |
0.36 | — | 68.62 | 13.61 | 7.33 | (0.71) | (1.70) | (6.04) | (27.25) |
Altman Z″-Score (non-manufacturers) |
(0.81) | (2.25) | (0.53) | 6.74 | (1.66) | (2.49) | (4.19) | (13.82) | (66.99) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
201.21 | (25.90) | (364.69) | (1,011.84) | (101.10) | (24.32) | (15.93) | (3.57) | (0.81) |
Beneish M-Score |
— | — | (1.96) | (2.19) | (3.63) | — | — | — | — |
P/B ratio |
1.75 | 1.50 | 1.47 | 4.08 | 4.86 | 0.98 | 1.15 | 0.62 | 0.00 |
Price to Tangible BV |
1.79 | 1.89 | 2.01 | 5.57 | 6.15 | 1.85 | 1.84 | 2.21 | 0.00 |
EV/Sales |
6.03 | 4.90 | 2.61 | 6.62 | 13.48 | 4.32 | 3.12 | 0.83 | 0.52 |
EV/EBITDA |
0.00 | 0.00 | 14.93 | 37.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(3.02) | (10.29) | (63.32) | (160.43) | (40.40) | (4.06) | (1.95) | (0.75) | (0.96) |
EV/FCF |
(1.84) | (9.31) | (28.36) | (71.85) | (19.10) | (2.80) | (1.74) | (0.72) | (0.89) |
Quick Ratio |
1.30 | 1.30 | 1.66 | 2.80 | 0.78 | 1.59 | 1.97 | 0.54 | 0.23 |
Current Ratio |
2.34 | 2.34 | 2.44 | 3.29 | 1.23 | 2.25 | 2.57 | 1.23 | 0.57 |
Net Debt/EBITDA |
(1.20) | (1.10) | (1.71) | (4.72) | 0.32 | 0.09 | 0.43 | (0.04) | (0.21) |
Debt/Assets |
26.10% | 26.10% | 21.88% | 4.73% | 3.84% | 2.33% | 6.15% | 11.59% | 74.21% |
Debt/Equity |
0.41 | 0.52 | 0.38 | 0.05 | 0.05 | 0.03 | 0.08 | 0.20 | (0.83) |
Asset Turnover |
0.43 | 0.21 | 0.39 | 0.27 | 0.26 | 0.23 | 0.23 | 0.33 | 0.77 |
Operating CF/Net income |
1.53 | 1.63 | 0.89 | (0.43) | 0.35 | 0.52 | 0.46 | 0.72 | 0.47 |
Capex/Depreciation |
(0.52) | 0.00 | 0.00 | 10.92 | (3.03) | (1.70) | (0.37) | (0.39) | (0.28) |
Interest Coverage |
(10.23) | (299.51) | (277.81) | 0.48 | (50.13) | (265.43) | (73.24) | (41.29) | (26.90) |
| (9.36%) | (12.46%) | 10.76% | 23.70% | (29.43%) | (57.00%) | (100.33%) | (75.58%) | (363.37%) | |
| (14.09%) | (7.07%) | 5.80% | 17.04% | (24.26%) | (46.78%) | (78.49%) | (51.37%) | (88.99%) | |
ROIC |
(11.33%) | 0.00% | 0.00% | 1.13% | (22.78%) | (73.94%) | (91.71%) | (86.11%) | 0.00% |
Return on Tangible Assets |
(10.64%) | (10.64%) | 8.92% | 25.67% | (44.87%) | (74.58%) | (133.79%) | (262.88%) | 375.98% |
Average Days of Receivables |
175.21 | 175.21 | 115.70 | 74.47 | 86.71 | 133.20 | 89.36 | 56.84 | 52.08 |
Research and Development Expense of Revenue |
29.07% | 28.92% | 10.15% | 51.18% | 29.50% | 9.70% | 5.43% | 1.80% | 0.92% |
Selling, General and Administrative Expense of Revenue |
61.89% | 59.36% | 33.62% | 53.20% | 62.54% | 218.62% | 180.29% | 124.06% | 88.23% |
Intangible Assets out of Total Assets |
0.13 | 0.13 | 0.17 | 0.12 | 0.16 | 0.40 | 0.28 | 0.42 | 0.13 |
Share Based Compensation of Revenue |
7.25% | 0.00% | 0.00% | 8.26% | 15.19% | 56.10% | 27.92% | 16.02% | 6.66% |
Graham Net Nets |
0.14 | 0.01 | 0.00 | 0.00 | 0.01 | 0.10 | 0.25 | (0.18) | (5.48) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 757.43 |
Earnings Yield |
(7.62%) | (2.54%) | 3.96% | 1.43% | (7.16%) | (41.84%) | (77.02%) | (193.36%) | (1,264.81%) |
Free Cash Flow Yield |
(50.63%) | (12.73%) | (4.08%) | (1.47%) | (5.14%) | (32.62%) | (40.07%) | (151.05%) | (480.73%) |
Revenue per Share |
320.36 | 0.00 | 14.59 | 383.79 | 327.33 | 345.83 | 408.78 | 404.62 | 178.18 |
Operating CF per Share |
(161.30) | 0.00 | 1.91 | (105.32) | (109.20) | (367.49) | (654.11) | (450.63) | (96.73) |
Capex per Share |
(18.39) | 0.00 | 0.00 | 527.88 | (121.74) | (166.80) | (80.75) | (19.66) | (2.58) |
Free Cash Flow per Share |
(179.70) | 0.00 | 1.91 | 422.56 | (230.95) | (534.29) | (734.86) | (470.30) | (99.31) |
Cash per Share |
184.01 | 0.00 | 5.34 | 369.79 | 132.14 | 194.24 | 691.18 | 72.52 | 6.81 |
Shareholders Equity per Share |
947.32 | 0.00 | 21.52 | 1,201.31 | 923.84 | 1,679.34 | 1,588.28 | 504.46 | (93.33) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
947.32 | 0.00 | 21.52 | 1,201.31 | 923.84 | 1,679.34 | 1,588.28 | 504.46 | (93.33) |
Free Cash Flow |
(9.74) | (9.43) | 4.26 | 23.75 | (13.14) | (34.35) | (63.64) | (56.72) | (29.33) |
Working Capital |
18.94 | 19.07 | 19.25 | 20.61 | 3.55 | 16.22 | 54.72 | 7.07 | (17.48) |
Capital Expenditures |
(1.00) | (1.00) | (3.50) | 29.67 | (6.93) | (10.73) | (6.99) | (2.37) | (0.76) |
Net Current Asset Value |
3.03 | 3.05 | 5.20 | 20.18 | 2.59 | 10.26 | 40.13 | (6.73) | (34.94) |
EV/EBIT |
0.00 | 0.00 | 24.65 | 62.47 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.06 | 0.00 | 0.00 | (1.38) | 0.37 | 0.48 | 0.20 | 0.05 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 21.31 | 59.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.06 | 0.06 | 0.08 | 0.08 | 0.06 | 0.14 | 0.51 | 0.28 | 1.94 |
Cash ROIC |
(11.80%) | (12.97%) | 5.45% | 25.83% | (20.95%) | (27.84%) | (30.46%) | (69.38%) | 1,128.56% |
Accounts Receivable Turnover |
2.08 | 2.09 | 3.48 | 2.93 | 4.22 | 3.55 | 4.22 | 6.00 | 6.97 |
Accounts Payable Turnover |
1.94 | 2.41 | 6.47 | 3.90 | 2.18 | 2.98 | 4.29 | 2.65 | 2.21 |
Inventory Turnover |
1.00 | 1.03 | 2.06 | 2.37 | 3.23 | 4.43 | 5.20 | 3.28 | 3.66 |
Average Days of Payables |
198.37 | 111.03 | 48.30 | 115.52 | 184.79 | 144.67 | 115.60 | 147.09 | 179.23 |
Days of Inventory on Hand |
366.11 | 356.09 | 147.22 | 90.07 | 109.28 | 105.64 | 100.69 | 110.53 | 86.17 |
Average Receivables |
8.34 | 8.36 | 9.35 | 7.35 | 4.41 | 6.27 | 8.39 | 8.13 | 7.55 |
Average Payables |
7.16 | 5.95 | 3.82 | 4.27 | 5.88 | 7.93 | 14.62 | 21.29 | 24.88 |
Average Inventory |
13.90 | 13.95 | 11.98 | 7.03 | 3.97 | 5.34 | 12.08 | 17.19 | 15.03 |
Average Assets |
40.68 | 81.64 | 82.77 | 80.27 | 72.84 | 97.82 | 156.92 | 145.95 | 67.94 |
Average Common Equity |
61.20 | 46.32 | 44.61 | 57.72 | 60.04 | 80.27 | 122.76 | 99.19 | 16.64 |
Columns are period end dates